about
Topical treatments for chronic plaque psoriasisTopical treatments for chronic plaque psoriasisA systematic review of evidence on the links between patient experience and clinical safety and effectivenessThe Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics.Development of an adherence-enhancing intervention in topical treatment termed the topical treatment optimization program (TTOP).Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists.'On the surface': a qualitative study of GPs' and patients' perspectives on psoriasis.[Adherence to treatment in chronic dermatosis: about 200 cases]Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Emerging drugs for psoriasis.Clinical, Quality of Life, Patient Adherence, and Safety Outcomes of Short-Course (12 Weeks) Treatment with Cyclosporine in Patients with Severe Psoriasis (the Practice Study).Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled studyDrug focus: adalimumab in the treatment of moderate to severe psoriasis.Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature.Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.Psoriasis care: new and emerging pharmacologic trends.Emerging treatments in the management of psoriasis: biological targeting with ustekinumab.Maximizing patient adherence for optimal outcomes in psoriasis.Adherence in the treatment of psoriasis: a systematic review.Adherence to topical treatment in psoriasis: a systematic literature review.Non-adherence and measures to improve adherence in the topical treatment of psoriasis.Quality of life in psoriasis patients.Barriers to guideline-compliant psoriasis care: analyses and concepts.Motivational interviewing-based training enhances clinicians' skills and knowledge in psoriasis: findings from the Pso Well® study.Care in the context of the complexity of psoriasis.Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam is Effective, Independent of Body Mass Index and the Extent and Severity of Psoriasis.Microsphere technology: hype or help?'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well® patient materials mixed-methods feasibility study.Myths and Facts about Vitiligo: An Epidemiological Study.Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison study.A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept.Potential barriers to adherence in pediatric dermatology.Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.Factors affecting adherence to treatment of psoriasis: comparing biologic therapy to other modalities.Eliciting preferences to inform patient-centred policies: the case of psoriasis.Patients' views of nurse prescribing: effects on care, concordance and medicine taking.German S3-guidelines on the treatment of psoriasis vulgaris (short version).
P2860
Q24198258-2B0D4B3E-5AF1-4E69-92F8-A7731D6C1835Q24241239-90EBF43D-94FA-4391-B33C-3F7B0F4CCF46Q30532682-5B2925D1-19C5-4530-843A-86F5D7997793Q33572834-81E6A8AB-F80D-4AE1-99DF-6B50C6BB8316Q34056113-1C6087BD-3498-4D3B-9326-0F9370498D22Q34071609-8E44BDAB-5FA8-4478-A1CA-F1DA2080FDB2Q34237346-0DDDCE66-2E22-4C83-95A4-0ABA09D31B5EQ35020447-0239CFE3-394C-4CAD-898C-57A60073CFC0Q36522267-E778E132-FFA3-40A8-BF09-502B9657CA03Q36628064-E1A6362D-138E-4D9D-BF9D-CB9D33277ADBQ36634244-5B4A9FBE-BD5A-4964-866E-B5A3E3503CA7Q36640532-9674C562-2CD9-4250-B69D-6773690AADC9Q36866954-1DF74D2F-8BA8-4701-ACBD-5385D4582510Q37290478-74ECCBFD-37B3-4FE3-AED1-0B4FF5A46F6EQ37427086-4C85A68C-0B67-4047-ABF4-EEB7018ED8F4Q37743492-789F739D-92C1-4E38-89ED-F9620F4D7AF3Q37757329-1B45F176-B53F-44D2-847C-A5358BFE3FC5Q37857668-63129D94-5291-4D3E-9022-42809AFABEAEQ37867174-1EE4F09D-C360-4105-96A4-E93B32940566Q37901280-6D789687-CBB6-4872-886E-C70D64C4B65BQ38003487-4CA7FE51-F446-40ED-ABB5-DDD3190E226CQ38200706-AED52F73-AE21-44D0-B54F-C744F7E9274AQ38211301-0F71D178-E270-4D21-ABEB-C6AB7E5EC61DQ38625686-5539AA25-F3F5-4BDB-B119-F6CF9D498887Q38845839-C5C406E7-D7A3-40A3-BB58-A61015F6FBBCQ39281885-C3E2BBAE-5664-4EBF-B60D-C0A8A2DFEBC8Q42364287-4252A721-E855-483E-AAC7-5A996A5627BEQ42697847-6F9F9EFA-D816-4828-920E-E89EA473063CQ42703641-EAE553CD-B2A5-4387-827D-202F61618634Q43182743-DC8B1322-B8B3-427A-8129-0AB308C7BC0AQ43550280-B8A470D1-FF0D-460A-BD55-9FA14390F166Q44546854-E0D2B559-DF65-4CCF-BD1E-D58D7595B173Q44773623-EAF9F9A3-CA0E-41AC-81CC-C6AF67F02B1FQ44966161-887E854E-A7A7-413C-A2E6-CB99EB9584C8Q45758119-A4987390-64CB-4C89-B91F-71B3BABA2F34Q45928983-D9F7163B-95F5-498F-B3F7-7F27812E9B92Q46703507-001741B9-C2B5-4FB6-ACA1-A9DE7F302994Q48093596-25AF104C-F0C3-4177-8824-E1F273724CD2Q48173552-97E050E3-2BCF-4AD3-AABB-382A12DB319CQ48480123-5E7E16CF-860A-405A-9093-F5292E00D1AE
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Adherence to treatment in patients with psoriasis.
@ast
Adherence to treatment in patients with psoriasis.
@en
type
label
Adherence to treatment in patients with psoriasis.
@ast
Adherence to treatment in patients with psoriasis.
@en
prefLabel
Adherence to treatment in patients with psoriasis.
@ast
Adherence to treatment in patients with psoriasis.
@en
P2860
P1476
Adherence to treatment in patients with psoriasis
@en
P2093
Fortune DG
Richards HL
P2860
P304
P356
10.1111/J.1468-3083.2006.01565.X
P577
2006-04-01T00:00:00Z